Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-19-000230

Chief Accounting Officer sold 8,000 shares at $26.37 ($210,960)

  • Chief Accounting Officer acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McKenzie Kathryn B · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-10 Exercise or conversion : show line 1 in the form +8,000 $8.03 $64,240 10,273 D
2019-12-10 Sale : show line 2 in the form −8,000 $26.37 $210,960 2,273 D
Open-market sales · 8,000 sh · avg $26.37 · $210,960

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-12-10 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −8,000 $8.03 2023-02-26 8,000 40,000 D
Loading xslF345X03/wf-form4_157619689019440.xml…